FDA panel recommends approval of Remicade for UC in children
HORSHAM, Pa. — A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.
J&J subsidiary Janssen Biotech, which formerly went under the name Centocor Ortho Biotech, said the FDA’s Gastrointestinal Drugs Advisory Committee recommended approval of Remicade (infliximab) for moderately to severely active ulcerative colitis in children who have not responded to conventional therapies. The FDA granted orphan drug designation to Remicade as a treatment for UC in children in 2003; the agency gives orphan drug designation to drugs for diseases that affect fewer than 200,000 people.
“We are pleased with the advisory committee’s support for the approval of Remicade as a treatment for pediatric ulcerative colitis,” said Jerome Boscia, VP and head of immunology development for the Centocor Research & Development division of J&J Pharmaceutical Research & Development. “We hope the FDA will consider this recommendation and approve Remicade for this orphan disease.”
AmerisourceBergen shows off new initiatives for Good Neighbor Pharmacy
VALLEY FORGE, Pa. — AmerisourceBergen on Thursday showcased a number of initiatives for its Good Neighbor Pharmacy independent franchise operations following its National Healthcare Conference and Exposition held in Las Vegas through the past week.
Those programs included a comprehensive brand marketing strategy under its Good Neighbor Pharmacy banner. “Offerings to the independent pharmacist include social media platforms with a national look and feel promoting community pharmacy, high-quality television commercials [that] play off a national branding campaign and advertisements customizable for their specific location — as well as availability in Spanish-language formats,” the company said.
“AmerisourceBergen understands that the community pharmacist plays an important role on the healthcare team,” AmerisourceBergen president David Neu said. “Good Neighbor Pharmacy is poised to support [pharmacists] with programs and solutions to help improve their business outcomes so they can focus their attention on caring for their patients.”
For Good Neighbor Pharmacy participants, AmerisourceBergen also highlighted its Business Coach and GNP InSite, a data analytics system that provides key performance indicators for the pharmacy. Good Neighbor Pharmacy members can leverage their data to find opportunities for growth, as well as examine benchmarks against their peers. The Business Coach helps to examine the pharmacy’s business practices and develop a plan for optimizing practices on prescription volume and mix, pricing, labor costs and scheduling, and technology assessments.
American Diabetes Association introduces guide for mothers with Type 1, Type 2, gestational diabetes
ALEXANDRIA, Va. — The American Diabetes Association has released a new guide catering to diabetic women that are planning to expand their brood and those who develop gestational diabetes during pregnancy.
The "American Diabetes Association’s Diabetes & Pregnancy: A Guide to a Healthy Pregnancy for Women Who Have Type 1, Type 2 or Gestational Diabetes" offers women ways to plan, conceive and deliver a healthy baby by providing tips on ways to prevent diabetes complications by properly managing blood-glucose levels, making lifestyle changes and taking medications.
The "American Diabetes Association’s Diabetes & Pregnancy: A Guide to a Healthy Pregnancy for Women Who Have Type 1, Type 2 or Gestational Diabetes" is available at ShopDiabetes.org, at bookstores nationwide or by calling (800) ADA-6733.